THE ETHICS OF INCIDENTAL FINDINGS: RECOMMENDATIONS FOR IRBS AND RESEARCHERS. Andy Kondrat, MA Bioethicist, Donnelley Ethics Program

Similar documents
Researcher Primer: Incidental and Secondary

For IRB Members: Incidental and Secondary Findings

For Clinicians: Incidental and Secondary Findings

Guidance on Returning Research Results to Subjects

Contents. I. Introduction

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CONSENT TO PARTICIPATE IN A RESEARCH STUDY

3/6/2017-6/15/2017 Permission to Take Part in a Human Research Study Page 1 of 6

RESEARCH CONSENT FORM

Title of Research Study: Discovery and Validation of Biomarkers for Lichen Sclerosus

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CONSENT TO BE IN RESEARCH

DFCI IRB RECOMMENDED CONSENT LANGUAGE RELATING TO RETURN OF RESEARCH RESULTS

Framework on the feedback of health-related findings in research March 2014

Language for Consent Forms

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CONSENT TO PARTICIPATE IN A RESEARCH STUDY

We are inviting you to participate in a research study/project that has two components.

IRB USE ONLY Approval Date: September 10, 2013 Expiration Date: September 10, 2014

Employee Education Working Partners

Employee Drug-Free Workplace Education

Preparing for an Oral Hearing: Taxi, Limousine or other PDV Applications

We are inviting you to participate in a research study/project that has two components.

Round robin summary - March 2012 Co-payment for unlicensed drug Egg donation Recruitment and training of Lay members

About this consent form

Human Research Ethics Committee. Some Background on Human Research Ethics

Northwestern University Department of Urology CONSENT FORM AND AUTHORIZATION FOR RESEARCH

INSTITUTIONAL REVIEW BOARD (IRB) PROCESS AND GUIDELINES FOR CONDUCTING RESEARCH AT ORANGE COAST COLLEGE

4. Adults Lacking Capacity to Consent to Research

UNIVERSITY HOSPITALS CASE MEDICAL CENTER CONSENT FOR INVESTIGATIONAL STUDIES (v )

IRB Approved: 09-Jan-2015 To: 08-Jan-2016

Day care and childminding: Guidance to the National Standards

UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM CONSENT TO PARTICIPATE IN A LONG TERM FOLLOW UP TO A RESEARCH STUDY AND RESEARCH SUBJECT HIPAA AUTHORIZATION

Wellness along the Cancer Journey: Palliative Care Revised October 2015

REQUIRED INSTITUTIONAL REVIEW BOARD (IRB) EDUCATIONAL READING FOR FLETCHER SCHOOL RESEARCHERS APPLYING FOR EXEMPTION FROM IRB

Deciding whether a person has the capacity to make a decision the Mental Capacity Act 2005

OUTPATIENT SERVICES PSYCHOLOGICAL SERVICES CONTRACT

Home Sleep Test (HST) Instructions

Mid Essex Specialist Dementia and Frailty Service

Research Ethics: A Brief Introduction. February 2017 Dina Shafey, Associate Director, ORE

MEMBER SHARE A Pastoral Medical Association - Private Membership Program MEMBER SHARE AGREEMENT (MSA)

Upperman Family Dental NEW PATIENT REGISTRATION

Sociology 301. Sampling + Research Ethics + Exam Review. Non-Probability Sampling

CONSENT TO GENETIC TESTING THROUGH A RESEARCH STUDY

UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM

About this consent form. Why is this research study being done? Partners HealthCare System Research Consent Form

DRAFT FOR PUBLIC COMMENT Guidance Note for ESS9 Financial Intermediaries

Testimony of. Eric J. Cassell, M.D., M.A.C.P. Member, National Bioethics Advisory Commission. and. Clinical Professor of Public Health

Mental Health Act 2007: Workshop. Section 12(2) Approved Doctors. Participant Pack

This report summarizes the stakeholder feedback that was received through the online survey.

Illumina Clinical Services Laboratory

Subject Name: Sponsor Consent Tmplt Date: Version 2 (17-Jul-2014) Unit Number:

FREQUENTLY ASKED QUESTIONS ABOUT MENTAL HEALTH ADVANCE DIRECTIVES GUIDE FOR CONSUMERS

2010 Sharing Hope Program for men

Setting up a Mental Health Support Group

JACKSONVILLE SPEECH & HEARING CENTER PATIENT INFORMATION FORM PEDIATRIC (CHILD) - AUDIOLOGY Please Print

HSPC/IRB Description of Research Form (For research projects involving human participants)

THE WORLD MEDICAL ASSOCIATION, INC. WMA STATEMENT ON ORGAN AND TISSUE DONATION

DIRECTIONS FOR USING THE MENTAL HEALTH ADVANCE DIRECTIVE POWER OF ATTORNEY FORM

IRB Approval From: 3/8/2010 To: 10/28/2010

Human Subject Institutional Review Board Proposal Form

Oregon Health & Science University Office of Research Integrity Guidance on Human Subjects Research with Decisionally Impaired Adults

UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM. A5272 Version 2.0, 5/19/11: Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy

Standards for Professional Conduct In The Practice of Dentistry

Getting to Know the Generation Program s Approach to Disclosing Information about Your Risk for Alzheimer s disease

DENTAL QUESTIONNAIRE

Guidelines for Ethical Conduct of Behavioral Projects Involving Human Participants by High School Students

NEBRASKA OCA PEER SUPPORT & WELLNESS SPECIALIST TRAINING APPLICATION January 23-27, 2012, Kearney, NE

NEWBORN SCREENING in Massachusetts: Answers for you and your baby

CLINICALLY SUPERVISED EXPERIENCE for the Criminal Justice Professional (PAGE 1 of 2) APPLICANT S NAME SUPERVISOR S NAME AGENCY

Canadian Mental Health Association

FIRST NAME MI LAST NAME BIRTH DATE (MM/DD/YYYY) GENDER. Name of person previously tested and relationship:

Model Intervention for Students with Substance Abuse Problems Act

Please take time to read this document carefully. It forms part of the agreement between you and your counsellor and Insight Counselling.

Vanderbilt University Institutional Review Board Informed Consent Document for Research. Name of participant: Age:

Code of Conduct for Communication Professionals

Ethical Caregiving What we Owe: The President s Council on Bioethics. William J. Kirkpatrick, LICSW

Presentation Preparation

RIGHTS OF DEAF AND HARD OF HEARING PEOPLE IN ENTERTAINMENT

CRC Screening Materials

IRB for Humanists. Naomi E. Coll, MPH, CPH, CIP Manager of Research Integrity

PrEP Impact Trial: A Pragmatic Health Technology Assessment of PrEP and Implementation. Part 1

One of Diabetes Queensland key strategies to improve lives is through research.

Course 1019 Trans-Disciplinary Ethical Principles & Responsibilities in Professional Counseling

Here4me Action for Children PROTOCOL FOR THE PROVISION OF ADVOCACY for West Berkshire

Royal College of Physicians, Committee on Ethical Issues in Medicine

INFORMATION BROCHURE - ALLOCATE

REGIONAL SPECIALIZED GERIATRIC SERVICES GOVERNANCE AUTHORITY. Call for Expressions of Interest from Seniors Advocate/Public Member

OHRP - Guidance on Research Involving Coded Private Information or Biological Specimens

Human Subjects Research: Overview. Colleen Kohashi and Tani Prestage Office for the Protection of Human Subjects (OPHS) February 26, 2016

Lynch Syndrome. patient guide. genetic testing for hereditary colorectal and uterine cancer

What happens if I cannot make decisions about my care and treatment?

Genetic Testing Program for Huntington s Disease

patient guide Clinical Genomics genetic testing for undiagnosed diseases Taking the extra step to find answers

Language Support Services Guidelines

Shepherd Integrative Physical Therapy

What s the name of your position?

Summary of Changes to Human Subjects Regulations: Effective January 21, 2019

DRUG TESTING FOR DISTRICT PERSONNEL REQUIRED TO HOLD A COMMERCIAL DRIVER S LICENSE

Washington County-Johnson City Health Department Christen Minnick, MPH, Director 219 Princeton Road Johnson City, Tennessee Phone:

EFFECTIVE COMMUNICATION IN MEDICAL SETTINGS

RAH s Regional Fertility & Women s Endocrine Clinic FAQs

Transcription:

THE ETHICS OF INCIDENTAL FINDINGS: RECOMMENDATIONS FOR IRBS AND RESEARCHERS Andy Kondrat, MA Bioethicist, Donnelley Ethics Program

OVERVIEW In December 2013, the Presidential Commission for the Study of Bioethical Issues released Anticipate and Communicate: Ethical Management of Incidental and Secondary Findings in the Clinical, Research, and Direct-to- Consumer Contexts The report reflects on the practical, legal, and ethical considerations that arise with incidental and secondary findings in the course of research, and provides recommendations based on these considerations

INCIDENTAL AND SECONDARY FINDINGS

SOURCES OF INCIDENTAL OR SECONDARY FINDINGS Large-scale genetic sequencing Behavioral studies/questionnaires Testing of biological specimens Imaging

PRACTICAL CONSIDERATIONS Range of researcher expertise Participant preferences Clinical significance of potential finding Cost of discovering and/or returning findings

LEGAL CONSIDERATIONS The Common Rule HIPAA CLIA Lack of any specific law or regulation

ETHICAL CONSIDERATIONS Respect for Persons Beneficence Justice and Fairness Intellectual Freedom and Responsibility

RESPECT FOR PERSONS Researchers demonstrate respect for participants by informing them about the possibility of discovering incidental or secondary findings and the plan for their disclosure or management including letting participants know that, in some circumstances, certain findings might not be disclosed at all (82-3).

BENEFICENCE [B]eneficence calls upon researchers and IRBs to consider whether the benefits of disclosing a finding outweigh the risks of disclosure (84).

JUSTICE AND FAIRNESS Allocating research resources to returning large numbers of incidental or secondary findings could burden the research enterprise and the ability to create generalizable knowledge (85).

INTELLECTUAL FREEDOM AND RESPONSIBILITY Researchers must take responsibility for their actions In this spirit, policies concerning the return of incidental or secondary findings should avoid excessively restrictive rules that might jeopardize and hinder progress in science, medicine, and health care (86).

RECOMMENDATIONS FOR RESEARCHERS Consent in the research context Planning for incidental findings No duty to look for secondary findings

CONSENT IN THE RESEARCH CONTEXT During the informed consent process, researchers should convey to participants the scope of potential incidental or secondary findings, and whether and how participants might opt out of receiving certain types of findings Photo Credit: Waag Society, https://www.flickr.com/photos/waagsociety/

PLANNING FOR ANTICIPATABLE INCIDENTAL FINDINGS Researchers should develop a plan to manage anticipatable incidental findings based on a balancing of the risks and benefits of disclosure, analytical and clinical validity, and clinical significance

PLANNING FOR UNANTICIPATABLE INCIDENTAL FINDINGS Researchers should develop a process for evaluating and managing unanticipatable findings, including the researchers responsibilities post-finding and method of disclosure to participants

NO DUTY TO LOOK FOR SECONDARY FINDINGS Both society at large and participants engaged in research have a vested interest in completed research that furthers scientific knowledge Prioritizing a duty to look for secondary findings over the creation of generalizable knowledge has the potential to undermine the research enterprise Photo credit: Jonathan Bennett, http://www.flickr.com/photos/jonanime/

RECOMMENDATIONS FOR IRBS IRBs should consider the following elements when reviewing plans to manage incidental findings: Informed Consent Researcher Expertise Participant Preferences Researcher Responsibilities

INFORMED CONSENT IRBs should evaluate whether the following elements have been considered and included in the consent material: Secondary Findings Anticipatable Incidental Findings Unanticipatable Findings

RESEARCHER EXPERTISE IRBs should verify that researchers either have the expertise to manage incidental findings, or have considered sources of additional expertise, including: Adding members to the research team Relying on research ethics consultants or the IRB Seeking consultation from experts on findings of uncertain clinical significance

PARTICIPANT PREFERENCES IRBs should review researcher plans for how they will return certain types of incidental or secondary findings, and how researchers will respect the wishes of those participants who wish to opt out of receiving findings

RESEARCHER RESPONSIBILITIES When reviewing a study application and consent form, an IRB should look to see that the researcher has described the team s responsibilities following disclosure of a finding Photo Credit: Helen K, https://www.flickr.com/photos/helenk/

CONCLUSIONS Have a plan for incidental findings, both those that are anticipatable and those that aren t As part of the informed consent process, inform potential participants of this plan, even if it includes not returning findings to them Manage any findings according to that plan

EXAMPLE 1: JOHNS HOPKINS MEDICINE Incidental Finding The (INSERT SPECIFIC TYPE OF IMAGING, e.g., MRI).you are having as part of this research study will be reviewed by a qualified person just as it would be if you were having the (INSERT SPECIFIC TYPE OF IMAGING, e.g., MRI) as part of your routine medical care. There is a possibility that while reviewing your (INSERT SPECIFIC TYPE OF IMAGING, e.g., MRI) we may see an abnormality that we did not expect to see in this study. This is what is called an "incidental finding. We will let you know (INSERT or your legal representative if appropriate for the study) if we see such an incidental finding. Depending on the type of incidental finding, we may contact you by mail or by phone. In the case of a potential serious emergency, someone may go to your home. A qualified person (usually a member of the research team) will talk to you if there is an incidental finding. You do not have an option to decline information about an incidental finding. If you want, we will give information about this incidental finding to your primary doctor or we will refer you to an appropriate doctor for further evaluation. An incidental finding may cause you to feel anxious. Since an incidental finding will be part of your medical record, it may affect your current or future life or health insurance coverage. This risk will vary depending on the type of insurance plan involved. The costs for any care that will be needed to diagnose or treat an incidental finding would not be paid for by this research study. These costs would be your responsibility. http://www.hopkinsmedicine.org/institutional_review_board/guidelines_policies /guidelines/incidental_findings.html

EXAMPLE 2: UNIVERSITY OF KENTUCKY Will you be given individual results from the research tests? Generally, tests done for research purposes are not meant to provide clinical information. Because the researchers will not have access to information that identifies you, the research findings will generally not be provided to you. There is a slight possibility that during a research project, a researcher could discover something that could affect the health of you or your family. If this occurs, the finding will be reviewed by (specify review by a special committee, an expert consultant) to determine if it is in your best interest to contact you. If so, (the bank, your primary/clinical care provider) will contact you at the contact information you provided. With the help of a (medical specialist, a genetic counselor), they will present possible risks or benefits of receiving the information. At that time you can choose to receive or refuse the result or finding. If you would like more information about this call. OR Do you give permission for (the bank, researchers) to contact you with information about research results or incidental findings that are determined to be important to you/your family s health? (Incidental findings are unforeseen findings discovered during the course of the research that may affect you or your family s health). Yes No Initials You may also withdraw your consent to be contacted with information about research results or incidental findings by sending a written request to (provide bank phone and mailing address). http://www.research.uky.edu/ori/oriforms/d58-issues-to- Address_Informed-Consent-for-Tissue-Specimen.pdf

EXAMPLE 3: DUKE UNIVERSITY Incidental Findings: It is possible that this study will identify information about you that was previously unknown, such as disease status or risk. There are no plans to provide this information to you or your physician unless the information indicates that you may be at risk for a serious illness known at the time of testing to be treatable. In that case, we will attempt to notify you using the contact information you have provided, so that you can speak with Dr. at Duke University Health System (DUHS). DUHS staff will not provide this information in a voice mail, email, or otherwise prior to contacting you. Please notify us of any change in your contact information. If you do not want to be notified of any incidental findings, please initial below. Please do not notify me of any incidental findings obtained from this research. If you prefer, we can ask you at the time of notification whether or not you want to receive incidental findings information. In this case, please initial below. Please ask me at the time of notification whether or not I want to receive incidental findings information. If at any time during or after the study you change your mind about whether or not you would like to be notified, you can contact us at. After providing the information to you, Dr. may arrange for you to meet with him/her and/or a genetic counselor or refer you to another appropriate health care provider to review the incidental findings information with you or your physician. http://irb.duhs.duke.edu/modules/irb_stdlng/index.php?id=1

EXAMPLE 4: NORTHWESTERN Disease testing and genetic research may produce results about your medical condition. One question for you to consider is whether you should know the results of the testing and research. Knowing the results has risks. The results may cause you anxiety and other psychological distress. Also, if you tell the results to your doctor, they may become part of your medical record. If released, the information could lead to health or life insurance discrimination, job or social discrimination. Knowing the results could also affect your future relationships with family members If applicable add: Because your family members are also part of this study, there is a risk that the results may show that some are your family members are not genetic relatives. (There is also a risk that other family members may learn private genetic information about you.) Not knowing results also has risks. It could mean that you will not have enough information regarding the need for treatment or the availability of a cure for a particular disease. http://irb.northwestern.edu/templates-forms/consent/genetic

Andy Kondrat akondrat@ric.org THANK YOU! QUESTIONS? COMMENTS?